Cover Image
Market Research Report

Cardiac Resynchronization Therapy Systems Market (Product - Cardiac Resynchronization Therapy Pacemaker, Cardiac Resynchronization Therapy Defibrillator) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Published by Transparency Market Research Product code 621285
Published Content info 156 Pages
Delivery time: 1-2 business days
Price
Back to Top
Cardiac Resynchronization Therapy Systems Market (Product - Cardiac Resynchronization Therapy Pacemaker, Cardiac Resynchronization Therapy Defibrillator) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Published: March 7, 2018 Content info: 156 Pages
Description

Global Cardiac Resynchronization Therapy Systems Market: Scope and Methodology

This report on the global Cardiac Resynchronization Therapy Systems Market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global diabetes devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global diabetes devices market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of various segments of global Cardiac Resynchronization Therapy Systems Market.

Cardiac Resynchronization Therapy Systems Market: Segmentation

Prevalence of heart failure is expected to increase exponentially worldwide due to change in lifestyle and various factors such as malnutrition, genetic mutations, and others. According to various government and private organizations operating in the cardiovascular industry, heart failure is considered one of the top reasons of mortality worldwide. Globally 26 million people are affected by heart failure. Cardiac resynchronization therapy (CRT) systems are used to treat conditions such as heart failure. The global Cardiac Resynchronization Therapy Systems Market can be segmented based on product type and region.

Depending on the product type the global Cardiac Resynchronization Therapy Systems Market includes - Cardiac Resynchronization Therapy Pacemaker and Cardiac Resynchronization Therapy Defibrillator. Cardiac resynchronization therapy pacemaker (CRT-P) also known as bi ventricular pacing is an implantable cardiac resynchronization therapy (CRT) pacemaker for patients with heart failure. The device monitors the heart's rhythm, detects irregularities and corrects them with electrical impulses. Cardiac resynchronization therapy defibrillator (CRT-D) is implanted in heart failure patients who are at a high risk of sudden cardiac arrest.

Cardiac Resynchronization Therapy Systems Market: Geographical and Competitive Dynamics

Geographically, the global Cardiac Resynchronization Therapy Systems Market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the Cardiac Resynchronization Therapy Systems Market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Medtronic, Boston Scientific Corporation, Abbott, LivaNova PLC, BIOTRONIK SE & Co. KG

The global Cardiac Resynchronization Therapy Systems Market is segmented as follows:

Global Cardiac Resynchronization Therapy Systems Market Revenue, by Product type

  • Cardiac Resynchronization Therapy Pacemaker
  • Cardiac Resynchronization Therapy Defibrillator

Global Cardiac Resynchronization Therapy Systems Market Revenue, by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
Table of Contents

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Research Approach & Methodology

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Global Diabetes Device Market Analysis and Forecasts, 2017-2025
  • 4.3. Global Cardiac Resynchronization Therapy Systems Market Outlook
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Global Prevalence of Heart Failure
  • 4.7. Recommendations for Cardiac Resynchronization Therapy (CRT)
  • 4.8. Regulatory Framework

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Opportunities
  • 5.5. Key Trends

6. Global Cardiac Resynchronization Therapy Systems Market Analysis, and Forecast by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Global Cardiac Resynchronization Therapy Systems Market Analysis, by Product Type
    • 6.2.1. Global Cardiac Resynchronization Therapy Systems Market Forecast, by Product Type
    • 6.2.2. Cardiac Resynchronization Therapy Pacemaker
    • 6.2.3. Cardiac Resynchronization Therapy Defibrillator

7. Global Cardiac Resynchronization Therapy Systems Market Analysis and Forecasts, By Region

  • 7.1. Global Cardiac Resynchronization Therapy Systems Snapshot, by Country
  • 7.2. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Middle East & Africa
    • 7.3.5. Latin America
  • 7.4. Market Attractiveness By Country/Region

8. North America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Trends
  • 8.2. Market Value Forecast By Product Type , 2017-2025
    • 8.2.1. Cardiac Resynchronization Therapy Pacemaker
    • 8.2.2. Cardiac Resynchronization Therapy Defibrillator
  • 8.3. Market Value Forecast By Country , 2017-2025
    • 8.3.1. U.S.
    • 8.3.2. Canada
  • 8.4. Market Attractiveness Analysis
    • 8.4.1. By Product Type
    • 8.4.2. By Country

9. Europe Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Trends
  • 9.2. Market Value Forecast By Product Type , 2017-2025
    • 9.2.1 Cardiac Resynchronization Therapy Pacemaker
    • 9.2.2. Cardiac Resynchronization Therapy Defibrillator
  • 9.3. Market Value Forecast By Country , 2017-2025
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. Italy
    • 9.3.4. Spain
    • 9.3.5. U.K.
    • 9.3.6. Rest of Europe
  • 9.4. Market Attractiveness Analysis
    • 9.4.1. By Product Type
    • 9.4.2. By Country

10. Asia Pacific Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Trends
  • 10.2. Market Value Forecast By Product Type , 2017-2025
    • 10.2.1. Cardiac Resynchronization Therapy Pacemaker
    • 10.2.2. Cardiac Resynchronization Therapy Defibrillator
  • 10.3. Market Value Forecast By Country , 2017-2025
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia & New Zealand
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Market Attractiveness Analysis
    • 10.4.1. By Product Type
    • 10.4.2. By Country

11. Middle East & Africa Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Trends
  • 11.2. Market Value Forecast By Product Type, 2017-2025
    • 11.2.1. Cardiac Resynchronization Therapy Pacemaker
    • 11.2.2. Cardiac Resynchronization Therapy Defibrillator
  • 11.3. Market Value Forecast By Country, 2017-2025
    • 11.3.1. GCC Countries
    • 11.3.2. South Africa
    • 11.3.3. Rest of MEA
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Product Type
    • 11.4.2. By Country

12. Latin America Cardiac Resynchronization Therapy Systems Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Trends
  • 12.2. Market Value Forecast By Product Type, 2017-2025
    • 12.2.1. Cardiac Resynchronization Therapy Pacemaker
    • 12.2.2. Cardiac Resynchronization Therapy Defibrillator
  • 12.3. Market Value Forecast By Country, 2017-2025
    • 12.3.1. Brazil
    • 12.3.2. Mexico
    • 12.3.3. Rest of Latin America
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Product Type
    • 12.4.2. By Country

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 13.2. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 13.2.1. Medtronic
      • 13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.1.2. Financial Overview
      • 13.2.1.3. Product Portfolio
      • 13.2.1.4. SWOT Analysis
      • 13.2.1.5. Strategic Overview
    • 13.2.2. Boston Scientific Corporation
      • 13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.2.2. Financial Overview
      • 13.2.2.3. Product Portfolio
      • 13.2.2.4. SWOT Analysis
      • 13.2.2.5. Strategic Overview
    • 13.2.3. Abbott
      • 13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.3.2. Financial Overview
      • 13.2.3.3. Product Portfolio
      • 13.2.3.4. SWOT Analysis
      • 13.2.3.5. Strategic Overview
    • 13.2.4. LivaNova PLC
      • 13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.4.2. Financial Overview
      • 13.2.4.3. Product Portfolio
      • 13.2.4.4. SWOT Analysis
      • 13.2.4.5. Strategic Overview
    • 13.2.5. BIOTRONIK SE & Co. KG
      • 13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.5.2. Financial Overview
      • 13.2.5.3. Product Portfolio
      • 13.2.5.4. SWOT Analysis
      • 13.2.5.5. Strategic Overview
    • 13.2.6. Asahi Kasei Medical Co., Ltd.
      • 13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.6.2. Financial Overview
      • 13.2.6.3. Product Portfolio
      • 13.2.6.4. SWOT Analysis
      • 13.2.6.5. Strategic Overview
    • 13.2.7. NIHON KOHDEN CORPORATION
      • 13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.7.2. Financial Overview
      • 13.2.7.3. Product Portfolio
      • 13.2.7.4. SWOT Analysis
      • 13.2.7.5. Strategic Overview
    • 13.2.8. Schiller AG
      • 13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.2.8.2. Financial Overview
      • 13.2.8.3. Product Portfolio
      • 13.2.8.4. SWOT Analysis
      • 13.2.8.5. Strategic Overview

List of Tables

  • Table 01: Opportunity Map, 2016
  • Table 02: Global Prevalence of Heart Failure (2015)
  • Table 03: Global Cardiac Resynchronization Therapy Systems Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 04: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 05: North America Cardiac Resynchronization Therapy Systems Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 06 North America Cardiac Resynchronization Therapy Systems Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 07: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 08: Europe Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 09: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 10: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 11: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 12: Latin America Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 13: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 14: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value (US$ Mn) Forecast, by Country, 2015-2025
  • Table 15: Medtronic, Products & Services Offered
  • Table 16: Medtronic Recent Developments
  • Table 17 :Boston Scientific Corporation, Products & Services Offered
  • Table 18: Boston Scientific Corporation, Recent Developments
  • Table 19: Abbott, Products & Services Offered
  • Table 20: Abbott, Recent Developments
  • Table 21: LivaNova PLC, Products & Services Offered
  • Table 22: LivaNova PLC , Recent Developments
  • Table 23: BIOTRONIK SE & Co. KG , Products & Services Offered
  • Table 24: Asahi Kasei Medical Co., Ltd., Products & Services Offered
  • Table 25: Asahi Kasei Medical Co., Ltd., Recent Developments and Achievements
  • Table 26: NIHON KOHDEN CORPORATION, Products Offered
  • Table 27: NIHON KOHDEN CORPORATION, Recent Developments
  • Table 28: Schiller, Products Offered

List of Figures

  • Figure 01: Global Cardiac Resynchronization Therapy Systems Market, by Product Type, Market Size (US$ Mn), 2017 (E)
  • Figure 02: Global Cardiac Resynchronization Therapy Systems Market Revenue (%), by Region, 2017 (E)
  • Figure 03: Executive Summary (2/3)
  • Figure 04: Executive Summary (3/3)
  • Figure 05: Key Industry Events and Developments
  • Figure 06: Global Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 07: Global Cardiac Resynchronization Therapy Systems Market Value Share, by product type (2016)
  • Figure 08: Global Cardiac Resynchronization Therapy Systems Market Value Share, by Region (2016)
  • Figure 09: Global Cardiac Resynchronization Therapy Systems Market
  • Figure 10: Global Cardiac Resynchronization Therapy Systems Market Value Share, by product Type, 2017 and 2025
  • Figure 11: Global Cardiac Resynchronization Therapy Systems Market Attractiveness, by Product Type, 2017-2025
  • Figure 12: Global Cardiac Resynchronization Therapy Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CRT-P, 2015-2025
  • Figure 13: Global Cardiac Resynchronization Therapy Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CRT-D, 2015-2025
  • Figure 14: Global Cardiac Resynchronization Therapy Systems Snapshot, by Country (1/1)
  • Figure 15: Global Cardiac Resynchronization Therapy Systems Value Share, by Region, 2017 and 2025
  • Figure 16: Global Cardiac Resynchronization Therapy Systems Attractiveness, by Region, 2017-2025
  • Figure 17: North America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 18: North America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
  • Figure 19: North America Cardiac Resynchronization Therapy Systems Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 20: North America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
  • Figure 21: North America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country
  • Figure 22: Drivers Impact Analysis for North America
  • Figure 23: Europe Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 24: Europe Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2016 and 2025
  • Figure 25: Europe Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 26: Europe Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
  • Figure 27: Europe Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region
  • Figure 28: Drivers Impact Analysis for Europe
  • Figure 29: Asia Pacific Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2025
  • Figure 30: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
  • Figure 31: Asia Pacific Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 32: Asia Pacific Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
  • Figure 33: Asia Pacific Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country
  • Figure 34: Drivers Impact Analysis for Asia Pacific
  • Figure 35: Latin America Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2025
  • Figure 36: Latin America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
  • Figure 37: Latin America Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 38: Latin America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
  • Figure 39: Latin America Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region
  • Figure 40: Drivers Impact Analysis for Latin America
  • Figure 41: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2025
  • Figure 42: Middle East &Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Product Type, 2017 and 2025
  • Figure 43: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2025
  • Figure 44: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Product Type
  • Figure 45: Middle East & Africa Cardiac Resynchronization Therapy Systems Market Attractiveness Analysis, by Country/Sub-region
  • Figure 46: Drivers Impact Analysis for Middle East & Africa
  • Figure 47: Competition Matrix (1/1)
  • Figure 48: Competition Matrix (2/2)
  • Figure 49: Medtronic, R&D Spending and Sales & Distribution Spending- Company Level or Segment Level, 2015-2016
  • Figure 50: Medtronic, Breakdown of Net Sales, by Business Segments, 2017
  • Figure 51 :Medtronic, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
  • Figure 52: Medtronic, Breakdown of Net Sales, By Region 2017
  • Figure 53: Boston Scientific Corporation, R&D Spending (Mn) and Sales & Distribution Spending (Mn) - Company Level or Segment Level, 2015-2016
  • Figure 54: Boston Scientific Corporation, Breakdown of Net Sales, by Business Segments, 2017
  • Figure 55 :Boston Scientific Corporation, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
  • Figure 56:Boston Scientific Corporation, Breakdown of Net Sales, By Region 2017
  • Figure 57:Abbott, R&D Spending and Sales & Distribution Spending- Company Level or Segment Level, 2015-2016
  • Figure 58: Abbott, Breakdown of Net Sales, by Business Segments, 2017
  • Figure 59: Abbott, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
  • Figure 60: Abbott, Breakdown of Net Sales, By Region 2017
  • Figure 61: LivaNova PLC, R&D Spending and Sales & Distribution Spending (US$ Mn)- Company Level or Segment Level, 2015-2016
  • Figure 62: LivaNova PLC, Breakdown of Net Sales, by Business Segments, 2017
  • Figure 63 : LivaNova PLC, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2017
  • Figure 64: LivaNova PLC, Breakdown of Net Sales, By Region 2017
  • Figure 65: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2012-2015
  • Figure 66: Asahi Kasei Medical Co., Ltd. R&D Intensity and Sales & Marketing Intensity Company Level, 2015-2016
  • Figure 67: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales, By Region (Segment Level-Connected Care & Health Informatics) 2016
  • Figure 68: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales, By Business Segments (Company Level) 2016
  • Figure 69: NIHON KOHDEN CORPORATION Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
  • Figure 70: NIHON KOHDEN CORPORATION R&D Intensity and Sales & Marketing Intensity (US$ Mn) - Company Level, 2016-2017
  • Figure 71: NIHON KOHDEN CORPORATION Breakdown of Net Sales, By Region (Company Level), March 31, 2017
  • Figure 72: NIHON KOHDEN CORPORATION Breakdown of Net Sales, By Business Segments March 31, 2017
Back to Top